Ali A, Emad N, Sultana N, Ali H, Jahan S, Aqil M
Iran J Basic Med Sci. 2024; 27(10):1228-1242.
PMID: 39229578
PMC: 11366951.
DOI: 10.22038/ijbms.2024.77888.16850.
Antony F, Kang X, Pundkar C, Wang C, Mishra A, Chen P
Int J Pharm. 2023; 640:123043.
PMID: 37172631
PMC: 10399699.
DOI: 10.1016/j.ijpharm.2023.123043.
Danquah M
Pharmaceuticals (Basel). 2022; 15(9).
PMID: 36145352
PMC: 9505931.
DOI: 10.3390/ph15091131.
Liu Z, Chen X, Huang Z, Wang H, Cao S, Liu C
Polymers (Basel). 2022; 14(4).
PMID: 35215606
PMC: 8879484.
DOI: 10.3390/polym14040694.
Sharma R, Calderon C, Vivas-Mejia P
Front Med Technol. 2022; 3:678593.
PMID: 35047931
PMC: 8757885.
DOI: 10.3389/fmedt.2021.678593.
Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles.
Mori T, Yoshida M, Hazekawa M, Ishibashi D, Hatanaka Y, Kakehashi R
Int J Mol Sci. 2021; 22(21).
PMID: 34769486
PMC: 8584378.
DOI: 10.3390/ijms222112056.
Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
Chang Y, Jiang J, Chen W, Yang W, Chen L, Chen P
Appl Mater Today. 2021; 18.
PMID: 34746366
PMC: 8570539.
DOI: 10.1016/j.apmt.2019.100492.
Hexaconazole-Micelle Nanodelivery System Prepared Using Different Surfactants for Ganoderma Antifungal Application.
Mustafa I, Hussein M, Idris A, Zainol Hilmi N, Fakurazi S
Molecules. 2021; 26(19).
PMID: 34641379
PMC: 8510315.
DOI: 10.3390/molecules26195837.
Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma.
Kumar V, Wang Q, Sethi B, Lin F, Kumar V, Coulter D
Biomaterials. 2021; 278:121138.
PMID: 34634662
PMC: 8573532.
DOI: 10.1016/j.biomaterials.2021.121138.
Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death.
Kang X, Cai Y, Wang Q, Wang C, Chen W, Yang W
Int J Pharm. 2021; 607:120972.
PMID: 34363916
PMC: 8567724.
DOI: 10.1016/j.ijpharm.2021.120972.
Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer.
Chen W, Yu D, Sun S, Li F
Acta Biomater. 2021; 129:258-268.
PMID: 34048974
PMC: 8273131.
DOI: 10.1016/j.actbio.2021.05.018.
Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity.
Barros C, Hiebner D, Fulaz S, Vitale S, Quinn L, Casey E
J Nanobiotechnology. 2021; 19(1):104.
PMID: 33849570
PMC: 8045376.
DOI: 10.1186/s12951-021-00851-2.
Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics.
Rai A, Noor S, Ahmad S, Alajmi M, Hussain A, Abbas H
Medicina (Kaunas). 2021; 57(2).
PMID: 33494239
PMC: 7909769.
DOI: 10.3390/medicina57020091.
New side chain design for pH-responsive block copolymers for drug delivery.
Ray P, Kale N, Quadir M
Colloids Surf B Biointerfaces. 2021; 200:111563.
PMID: 33454622
PMC: 9387087.
DOI: 10.1016/j.colsurfb.2021.111563.
Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer.
Bhattarai R, Kumar V, Romanova S, Bariwal J, Chen H, Deng S
J Control Release. 2020; 329:585-597.
PMID: 33010334
PMC: 7904572.
DOI: 10.1016/j.jconrel.2020.09.052.
A library of aminoglycoside-derived lipopolymer nanoparticles for delivery of small molecules and nucleic acids.
Godeshala S, Miryala B, Dutta S, Christensen M, Nandi P, Chiu P
J Mater Chem B. 2020; 8(37):8558-8572.
PMID: 32830211
PMC: 8291345.
DOI: 10.1039/d0tb00924e.
New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: optimization and improved therapeutic efficacy.
Hammad R, Sanad R, Abdelmalak N, Torad F, Latif R
J Adv Res. 2020; 23:83-94.
PMID: 32089877
PMC: 7025289.
DOI: 10.1016/j.jare.2020.01.013.
Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment.
Bariwal J, Kumar V, Chen H, Bhattarai R, Peng Y, Li W
J Control Release. 2019; 309:231-243.
PMID: 31330213
PMC: 6815718.
DOI: 10.1016/j.jconrel.2019.07.025.
Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate Cancer.
Yang R, Chen H, Guo D, Dong Y, Miller D, Li W
J Pharmacol Exp Ther. 2019; 370(3):864-875.
PMID: 30996033
PMC: 6806635.
DOI: 10.1124/jpet.119.256628.
Strategies to improve micelle stability for drug delivery.
Lu Y, Zhang E, Yang J, Cao Z
Nano Res. 2018; 11(10):4985-4998.
PMID: 30370014
PMC: 6201237.
DOI: 10.1007/s12274-018-2152-3.